GlassScriptPhysician profile
Richard E Helmer
NPI 1881898666
$8,975.27
in general payments reported to CMS, 2019-2025
22 companies · $1,989 in 2025
The $1,989 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,789 · 2020: $302 · 2021: $528 · 2022: $873 · 2023: $843 · 2024: $1,650 · 2025: $1,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,014 · Travel and Lodging: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,014.19 |
| Travel and Lodging | $468.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,713.97 | 2019-2024 | Da Vinci Surgical System |
| Stryker Corporation | $1,125.82 | 2024-2025 | Chromophare F300, Flowtriever, Ct Thrombectomy System Kit |
| Atricure, INC. | $1,033.70 | 2022-2024 | |
| Abiomed | $744.06 | 2023-2025 | Impella |
| Inari Medical, INC. | $424.88 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pylant Medical | $345.81 | 2025 | |
| Abbott Laboratories | $300.38 | 2024-2025 | Assurity, Aveir, Cardiomems |
| Edwards Lifesciences Corporation | $236.34 | 2019-2023 | Hemosphere |
| Astrazeneca Pharmaceuticals LP | $180.52 | 2024-2025 | Farxiga, Andexxa, Wainua |
| Medtronic, INC. | $177.51 | 2024-2025 | Corevalve Evolut R, Symplicity G3 |
| W. L. Gore & Associates, INC. | $123.62 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.23 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.34 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $100.99 | 2024-2025 | Camzyos, Eliquis |
| Amgen INC. | $64.06 | 2024-2025 | Repatha |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $46.14 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.87 | 2025 | |
| Solventum Corporation | $25.93 | 2025 | Prevena |
| Biotronik INC. | $18.80 | 2025 | Solia |
| Boston Scientific Corporation | $18.25 | 2025 | Enroute Transcarotid Neuroprotection System |
| Neuros Medical, INC. | $18.17 | 2025 | Altius |
| Lemaitre Vascular, INC. | $14.88 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Helmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.